152 related articles for article (PubMed ID: 36426734)
1. Cryptococcal antigenemia in people living with HIV and AIDS.
Ahuja J; Soneja M; Wig N; Biswas A; Xess I; Singh G; Vibha D; Nischal N
Int J STD AIDS; 2023 Feb; 34(2):130-136. PubMed ID: 36426734
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic Cryptococcal Antigenemia in People Living with HIV (PLHIV) with Severe Immunosuppression: Is Routine CrAg Screening Indicated in India?
Anuradha S; H AN; Dewan R; Kaur R; Rajeshwari K
J Assoc Physicians India; 2017 Apr; 65(4):14-17. PubMed ID: 28527158
[TBL] [Abstract][Full Text] [Related]
4. Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi.
Chisale MRO; Jordan A; Kamudumuli PS; Mvula B; Odo M; Maida A; Kandulu J; Chilima B; Sinyiza FW; Katundu P; Lee HY; Mtegha R; Wu TJ; Bitirinyo J; Nyirenda R; Kalua T; Greene G; Chiller T
PLoS One; 2023; 18(5):e0284367. PubMed ID: 37141243
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.
Mpoza E; Rajasingham R; Tugume L; Rhein J; Nabaggala MS; Ssewanyana I; Nyegenye W; Kushemererwa GE; Mulema V; Kalamya J; Kiyaga C; Kabanda J; Ssali M; Boulware DR; Meya DB
Clin Infect Dis; 2020 Oct; 71(7):1726-1731. PubMed ID: 31679007
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.
Beyene T; Woldeamanuel Y; Asrat D; Ayana G; Boulware DR
PLoS One; 2013; 8(10):e75585. PubMed ID: 24124498
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
[TBL] [Abstract][Full Text] [Related]
8. Screening for cryptococcal antigen in asymptomatic people with HIV: urgent need in Eastern India.
Chakravarty J; Reddy S; Gupta MK; Tilak R; Diwaker C; Sundar S
AIDS; 2023 Dec; 37(15):2359-2363. PubMed ID: 37650766
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.
Montgomery MP; Nakasujja N; Morawski BM; Rajasingham R; Rhein J; Nalintya E; Williams DA; Huppler Hullsiek K; Kiragga A; Rolfes MA; Donahue Carlson R; Bahr NC; Birkenkamp KE; Manabe YC; Bohjanen PR; Kaplan JE; Kambugu A; Meya DB; Boulware DR;
BMC Neurol; 2017 Jun; 17(1):110. PubMed ID: 28606065
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
11. Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease.
Yoon H; Wake RM; Nakouzi AS; Wang T; Agalliu I; Tiemessen CT; Govender NP; Jarvis JN; Harrison TS; Pirofski LA
Clin Infect Dis; 2023 Feb; 76(4):649-657. PubMed ID: 35915964
[TBL] [Abstract][Full Text] [Related]
12. Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India.
Acharya S; Allam RR; Karanjkar VK; Rathod D; Mahajan R; Deshpande P; Palkar A; Todmal S; Koli S; Dhande S; Dale J; Yeldandi VV; Harshana A; Agarwal R; Upadhyaya S; Nyendak M
BMJ Open; 2023 Jun; 13(6):e070500. PubMed ID: 37349096
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
[TBL] [Abstract][Full Text] [Related]
14. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Sequelae of Cryptococcal Antigenemia in Antiretroviral Therapy-Experienced Populations: An Evaluation of Reflex Cryptococcal Antigen Screening in Botswana.
Hurt WJ; Tenforde MW; Molefi M; Mitchell HK; Milton T; Azama MS; Goercke I; Mulenga F; Tlhako N; Tsholo K; Srivastava T; Leeme TB; Simoonga G; Muthoga C; Lechiile K; Mine M; Jarvis JN
Clin Infect Dis; 2021 May; 72(10):1745-1754. PubMed ID: 32236414
[TBL] [Abstract][Full Text] [Related]
17. High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
Wake RM; Britz E; Sriruttan C; Rukasha I; Omar T; Spencer DC; Nel JS; Mashamaite S; Adelekan A; Chiller TM; Jarvis JN; Harrison TS; Govender NP
Clin Infect Dis; 2018 Feb; 66(5):686-692. PubMed ID: 29028998
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.
Wake RM; Govender NP; Omar T; Nel C; Mazanderani AH; Karat AS; Ismail NA; Tiemessen CT; Jarvis JN; Harrison TS
Clin Infect Dis; 2020 Apr; 70(8):1683-1690. PubMed ID: 31179488
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
Alemu AS; Kempker RR; Tenna A; Smitson C; Berhe N; Fekade D; Blumberg HM; Aseffa A
PLoS One; 2013; 8(3):e58377. PubMed ID: 23469276
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcal antigenemia in anti-retroviral naïve AIDS patients: prevalence and its association with CD4 cell count.
Osazuwa OF; Dirisu O; Okuonghae E
Acta Med Iran; 2012; 50(5):344-7. PubMed ID: 22837089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
